UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 274

Sortiert nach

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2191-2197

2010

Volltextzugriff (PDF)

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis

BMC cancer, 2020-04, Vol.20 (1), p.276-6, Article 276

2020

Volltextzugriff (PDF)

The Cost of Poor Sleep: Workplace Productivity Loss and Associated Costs

Journal of occupational and environmental medicine, 2010-01, Vol.52 (1), p.91-98

2010

Volltextzugriff (PDF)

Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer

Journal of managed care & specialty pharmacy, 2016-03, Vol.22 (3), p.227

2016

Volltextzugriff (PDF)

Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer

BMC cancer, 2021-07, Vol.21 (1), p.1-11, Article 824

2021

Volltextzugriff (PDF)

Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in SEER-Medicare

Medical care, 2015-08, Vol.53 (8), p.e58-e64

2015

Volltextzugriff (PDF)

Management of hepatocellular carcinoma from diagnosis in routine clinical practice

Hepatic oncology, 2022-12, Vol.9 (4), p.HEP45-HEP45

2022

Volltextzugriff (PDF)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA

Hepatic oncology, 2021-09, Vol.8 (3), p.HEP37-HEP37

2021

Volltextzugriff (PDF)

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting

Hepatic oncology, 2023-03, Vol.10 (1), p.HEP47-HEP47

2023

Volltextzugriff (PDF)

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study

Cancer reports, 2022-05, Vol.5 (5), p.e1504-n/a

2022

Volltextzugriff (PDF)

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone

PloS one, 2017-04, Vol.12 (4), p.e0175956

2017

Volltextzugriff (PDF)

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients

Journal of managed care & specialty pharmacy, 2016-06, Vol.22 (6), p.628

2016

Volltextzugriff (PDF)

Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC): A Systematic Literature Review

Value in health, 2013-07, Vol.16 (5), p.872-890

2013

Volltextzugriff (PDF)

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US

JAMA oncology, 2021-12, Vol.7 (12), p.1824

2021

Volltextzugriff (PDF)

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I

Value in health, 2010, Vol.13 (1), p.3-7

2010

Volltextzugriff (PDF)

Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer

Urologic oncology, 2017-04, Vol.35 (4), p.150.e17-150.e23

2017

Volltextzugriff (PDF)

Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative US Claims Database

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2014-04, Vol.28 (2), p.229-236

2014

Volltextzugriff (PDF)

Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival

Value in health, 2013-07, Vol.16 (5), p.760-768

2013

Volltextzugriff (PDF)

Asthma costs and utilization in a managed care organization

Journal of allergy and clinical immunology, 2008-04, Vol.121 (4), p.885-892.e5

2008

Volltextzugriff (PDF)

Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients

American journal of health-system pharmacy, 2010-12, Vol.67 (24), p.2110-2114

2010

Volltextzugriff (PDF)

The lines of loco-regional therapies received and the healthcare economic burden of patients newly diagnosed with hepatocellular carcinoma in the United States

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.286-286

2021

Volltextzugriff (PDF)

Treatment patterns in extensive-stage small cell lung cancer: A retrospective real-world data study

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.288-288

2020

Volltextzugriff (PDF)

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients

Cancer medicine (Malden, MA), 2013-12, Vol.2 (6), p.907-915

2013

Volltextzugriff (PDF)

Adoption of immune checkpoint inhibitors (ICI) for unresectable locally advanced or metastatic urothelial carcinoma (u/mUC): A retrospective assessment of community oncology practices

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.293-293

2021

Volltextzugriff (PDF)

Healthcare utilization and costs in hepatocellular carcinoma (HCC) patients treated at a large referral center in Washington (WA) State

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16149-e16149

2021

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Englisch
(273)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis

The Cost of Poor Sleep: Workplace Productivity Loss and Associated Costs

Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer

Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer

Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in SEER-Medicare

Management of hepatocellular carcinoma from diagnosis in routine clinical practice

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study

Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone

Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients

Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC): A Systematic Literature Review

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I

Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer

Systemic Therapy for Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in Nationally Representative US Claims Database

Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival

Asthma costs and utilization in a managed care organization

Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients

The lines of loco-regional therapies received and the healthcare economic burden of patients newly diagnosed with hepatocellular carcinoma in the United States

Treatment patterns in extensive-stage small cell lung cancer: A retrospective real-world data study

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients

Adoption of immune checkpoint inhibitors (ICI) for unresectable locally advanced or metastatic urothelial carcinoma (u/mUC): A retrospective assessment of community oncology practices

Healthcare utilization and costs in hepatocellular carcinoma (HCC) patients treated at a large referral center in Washington (WA) State

Suchergebnisse filtern